Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC4640 Sch-202596
Natural selective non-peptide antagonist for the receptor GAL-1
More description
DCC4639 Scalaradial
Natural Potent Inhibitor of Transient Receptor Potential Melastatin 2 (TRPM2) Ion Channels
More description
DCC4638 Scacer2
Novel photoswitchable substrate for sphingomyelin synthase 2 (SMS2), enabling optical control of apoptosis and being ready for azide-alkyne click chemistry
More description
DCC4637 Scacer1
Novel photoswitchable substrate for sphingomyelin synthase 2 (SMS2), enabling optical control of apoptosis and being ready for azide-alkyne click chemistry
More description
DCC4636 Sc-75416
Novel selective COX-2 inhibitor
More description
DCC4635 Sc-68376
Potent and selective inhibitor of p38 MAP kinase
More description
DCC4634 Sc-558
Selective COX-2 inhibitor
More description
DCC4633 Sc-53228
Second-generation leukotriene B4 receptor antagonist
More description
DCC4632 Sc-44463
Matrix metalloproteinase (MMP) inhibitor, also acting as a collagenase inhibitor
More description
DCC4631 Sc-203885
Potent inhibitor of checkpoint kinase 2 (Chk2)
More description
DCC4630 Sc-2001
Novel obatoclax derivative, inducing apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation
More description
DCC4629 Sbp-0636457
Novel Smac mimetic, demonstrating potent cell-killing effects in several subtypes of breast, ovarian, and prostate cancer cell lines but only when the DR ligand TRAIL or another such apoptosis inducer is co-administered
More description
DCC4628 Sbi4211
Inhibitor of S100B which selectively kills melanoma; Amoebicidal diamidine
More description
DCC4627 Sbi-183
Novel inhibitor of Quiescin Sulfhydryl Oxidase 1 (QSOX1), suppresses tumor cell growth in a Matrigel-based spheroid assay and inhibits invasion in a modified Boyden chamber, but does not affect viability of non-malignant cells
More description
DCC4626 Sbi-0069332
Novel potentiator of metabotropic glutamate receptors for use against neurological and psychiatric disorders
More description
DCC4625 Sbi-0061869
Novel potentiator of metabotropic glutamate receptors for use against neurological and psychiatric disorders
More description
DCC4624 Sbfi-am
Membrane-permeant, fluorescent, selective Na+ indicator dye
More description
DCC4623 Sbc219
Novel cAMP-independent potentiator of CFTR, synergistically restoring CFTR function
More description
DCC4622 Sbc040
Novel cAMP-independent potentiator of CFTR, synergistically restoring CFTR function
More description
DCC4621 Sb-790594-a
Potent non-cytotoxic inhinitor of Mycobacterium tuberculosis H37Rv
More description
DCC4620 Sb-7720770 Dihydrochloride
Novel Rho kinase inhibitor
More description
DCC4619 Sb-744941
Novel inhibitor of mitogen and Stress-Activated Kinases 1 (MSK1)
More description
DCC4618 Sb-656933
Novel CXCR2 selective antagonist, inhibiting ex vivo neutrophil activation and ozone-induced airway inflammation in humans
More description
DCC4617 sb-649915
Novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor
More description
DCC4616 Sb-414796
Potent and selective dopamine D3 receptor antagonist
More description
DCC4615 Sb-390570
Novel TRPV4 blocker
More description
DCC4614 Sb-354364
AntiMycobacterium tuberculosis agent
More description
DCC4613 Sb-284851-bt
Selective p38a kinase inhibitor, inhibiting Brd4
More description
DCC4612 Sb-277011a Dihydrochloride
Selective dopamine D3 receptor antagonist
More description
DCC4611 Sb-267268
Nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reducing angiogenesis and VEGF expression
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X